BCR-ABL tyrosine kinase domain mutations combinations affects imatinib resistence in chronic phase chronic myelogenous leukemia

Siprianus Ugroseno Yudho Bintoro
, P. N.A. Amrita
, E. Joewarini
, P. Suryohusodo
, S. Soebandiri

Research output: Contribution to journal › Article › peer-review

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science